HSCT may lower leukemia risk in ELANE neutropenia: a before–after study from the French Severe Congenital Neutropenia Registry

Autor: Yves Bertrand, Blandine Beaupain, Despina Moshous, Ouahiba Nachit, Nathalie Aladjdi, Bruno Filhon, Flore Sicre de Fontbrune, Christine Bellanné-Chantelot, Jean-Hugues Dalle, Benedicte Neven, Gioacchino Andrea Rotulo, Fanny Rialland, J. Donadieu, Marie Ouachee, E. Dore, Catherine Paillard, Claire Galambrun, Virginie Gandemer, Regis Peffault de la Tour

Publikováno v: Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2020, 55 (8), pp.1614-1622. ⟨10.1038/s41409-020-0800-1⟩

International audience; ELANE neutropenia is associated with myelodysplasia and acute leukemia (MDS–AL), and severe infections. Because the MDS–AL risk has also been shown to be associated with exposure to GCSF, since 2005, in France, patients re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4fd74c9fbfdad5dd60e21981951c011
https://hal.sorbonne-universite.fr/hal-02996434/document